Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial

Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial

Abstract This exploratory analysis of the Neoadjuvant Carboplatin in Triple Negative Breast Cancer (NACATRINE) study aimed to identify the biomarkers of pathological complete response (pCR) in patients with triple-negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NAC) within the c...

Full description

Bibliographic Details
Main Authors: Ana Julia Aguiar Freitas, Caroline Rocha Nunes, Max Senna Mano, Rhafaela Lima Causin, Iara Viana Vidigal Santana, Marco Antonio de Oliveira, Stéphanie Calfa, Henrique César Santejo Silveira, Cristiano de Pádua Souza, Márcia Maria Chiquitelli Marques
Format: Article
Language:English
Published: Nature Portfolio 2023-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-48657-6

Internet

https://doi.org/10.1038/s41598-023-48657-6

Similar Items